StockNow
Log in
Global Markets

Roche's (ROP SW) obesity product development head says the latest obesity drug results are reassuring, is confident that enicepatide will achieve higher weight loss in new studies

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US Treasury official says the latest removal of sanctions on Iran is not indicative of any shift in US policy toward the Government of Iran, Fox's Heinrich reports

Fed

Fed's Kashkari (2026 voter, Hawkish dissenter) says now is the time to start slowly moving up rates, but not calling for dramatic rate hikes

Geopolitics

Arab sources report missile attack on Bahrain, Fars reports